Neutrogena T/Gel 2 in1 Daily Control Shampoo Plus Conditioner | Neutrogena Tgel Daily Control 2 in 1
Drug Facts
Pyrithione Zinc 1%
Anti-Dandruff, Anti-Seborrheic Dermatitis
Controls the symptoms of Dandruff and Seborrheic Dermatitis
For external use only
Ask a doctor before use if you have a condition that covers a large area of the body.
When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
WaterSodium Laureth SulfateCocamidopropyl BetaineAmmonium Lauryl SulfateSodium Methyl Cocoyl TaurateDivinyldimethicone/Dimethicone CopolymerC12-13 Pareth-3C12-13 Pareth-23Castor Isostearate SuccinateGuar Hydroxypropyltrimonium ChlorideHydrolyzed Wheat Protein PG Propyl SilanetriolTocopheryl AcetateAmodimethiconeCetearyl AlcoholCeteareth-20Castor Isostearate SuccinateSodium HydroxideSodium ChlorideAcrylates CopolymerDMDM HydantoinBlue 1Fragrance
Call 1-877-256-4247 (USA only) or www.tgel.com
NEUTROGENA dailycontrol from the makers of T/Gel 2 in 1 Dandruff ShampooPlus Conditioner
clinically provendandruff protectionthat's extra gentle on hair
#1 DERMATOLOGISTRECOMMENDED BRAND
Neutrogena 1% PYRITHIONE ZINC 8.5 FL OZ (250mL)
40023024
Manufacturer
Neutrogena Corporation
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 4 May 2013
Drugs and Medications
Neutrogena t/sal [Neutrogena Corporation]
Neutrogena T/Sal Therapeutic Shampoo
Neutrogena t/gel therapeutic [Neutrogena Corporation]
Neutrogena T/Gel Therapeutic Shampoo Kit
Neutrogena healthy skin [Neutrogena Corporation]
Neutrogena Healthy Skin Firming Cream SPF 15 – Firms & Lifts
Neutrogena all in 1 acne control [Neutrogena Corporation]
Neutrogena All-in-1 Acne Control Daily Scrub
Neutrogena skinid anti acne treatment [Neutrogena Corporation]
Neutrogena SkinID Anti-Acne Treatment
Clinical Trials
A double-blind study comparing Esomeprazole Magnesium 40 mg once daily and Lansoprazole 30 mg twice daily to control the symptoms in patients with gastroesophageal reflux disease (GERD) wi...
The purpose of this study is to compare the safety and efficacy of 5% Dapsone Topical Gel, (DTG) twice daily in combination with once daily vehicle control, adapalene gel 0.1% or benzoyl p...
This was a randomized, double-blind, parallel-group, multicenter study that used both an active control (cetirizine) and a placebo control to evaluate desloratadine 5 mg once daily during...
This was a randomized, double-blind, parallel-group, multicenter study that used both an active control (cetirizine) and a placebo control to evaluate desloratadine 5 mg once daily during...
The objective of the study is to investigate the efficacy and safety of linagliptin 2.5 mg twice daily compared to 5 mg once daily compared to placebo given orally for 12 weeks as add-on t...
PubMed Articles
Perceived control over diabetes may serve to buffer the relationship between adolescents' experience of daily negative affect and daily problems with diabetes. In a daily diary study including 209 ado...
Once- vs Twice-Daily Budesonide/Formoterol in 6- to 15-Year-Old Patients With Stable Asthma.
Objective: To assess efficacy/tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler (pMDI) versus budesonide pMDI (primary) and twice-daily budesonide/formoterol (secondary...
Once-daily indacaterol vs twice-daily salmeterol for COPD: a placebo-controlled comparison.
Indacaterol is a novel, inhaled, once-daily, ultra-long-acting beta2-agonist bronchodilator, recently approved in Europe for the treatment of COPD. This study set out to investigate the efficacy and s...
Worktime control-dependent reductions in fatigue, sleep problems, and depression.
We investigated the association between worktime control and fatigue, sleep problems, and depressive symptoms in a sample of daytime and shift workers. A total of 3681 permanent daytime workers and 59...
OBJECTIVE: Despite the lack of any scientific data, many ART programs split the daily gonadotropin dose during ovarian stimulation, while others give the entire dose during a sin...
